MIDFOINT

MIDFOINT is an innovative monophasic hyaluronic acid (HA) filler developed by DNC, tailored for delicate facial areas like the under-eyes and lips. It focuses on enhancing natural volume while addressing wrinkles and volume loss. MIDFOINT represents a leap in medical aesthetics, offering an ideal balance of softness, elasticity, and durability for targeted areas.

Core Characteristics of MIDFOINT

• Monophasic Filler Design: Unlike biphasic fillers with separate gel and particle phases, MIDFOINT boasts a uniform particle distribution, ensuring smooth integration into the skin. This minimizes the foreign sensation post-injection and delivers a soft, natural look.
• Physical Properties: MIDFOINT’s finely tuned particle uniformity contributes to its cohesive and malleable texture. This property allows for easy molding and precise application, crucial for thin-skinned areas.
• R&D Excellence: Developed over three years, this filler overcomes common issues in elasticity, volume retention, and injection ease. Its balanced viscoelasticity ensures both softness and structural integrity.
• Clinical Effectiveness: Particularly effective for treating fine lines and restoring volume in sensitive facial regions, MIDFOINT ensures patient comfort and long-lasting results.
• Market Aim: DNC positions MIDFOINT as a top-tier option in Korea’s highly competitive filler market by focusing on quality and advanced formulation.

MIDFOINT must be stored at temperatures between 2°C and 25°C in a cool, dry environment. Proper storage prevents degradation, maintaining the product’s performance.